LONDON, June 15, 2023 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. With this ...
Hikma is introducing dobutamine injection, in a 250 mg/20 ml vial. With this launch, Hikma’s growing U.S. portfolio of sterile injectable medicines now exceeds 150 products spanning a wide range of ...
Hospira announced a nationwide recall for one lot of Dobutamine Injection, 250mg, 20mL, single-dose fliptop vial. This recall was following a customer report of discolored solution. A closer ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Dobutamine Hydrochloride Injection contains the active ingredient ...
Dobutamine (K .M. Dobutamine) is a sympathomimetic compound used in the treatment of heart failure and cardiogenic shock. It stimulates the heart muscle. The information provided on this page is ...
Dobutamine (Dobustat (20 ml)) is a sympathomimetic compound used in the treatment of heart failure and cardiogenic shock. It stimulates the heart muscle. The information provided on this page is ...
Tirofiban hydrochloride injection 0.05 mg/mL was stable for at least four hours at room temperature when combined 1:1 in glass containers with atropine sulfate, dobutamine, epinephrine hydrochloride, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results